CLDN10, a glandular epithelial marker in epithelial ovarian cancer (Seo et al., 2010), was reported to be a key immune-related gene in clear cell renal cell carcinoma (Yang et al., 2021) and papillary thyroid carcinoma (Xiang et al., 2020). This evidence concerns the gene CLDN10 and ovarian carcinoma.